U.S. market Closed. Opens in 1 day 10 hours 54 minutes

CRVS | Corvus Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue151.00K367.00K460.00K632.00K743.00K847.00K842.00K594.00K148.00KN/A
Gross Profit-151.00K-367.00K-460.00K-632.00K-743.00K-847.00K-842.00K-594.00K-148.00KN/A
Operating Expenses23.41M32.56M38.63M43.76M48.85M49.22M56.52M36.98M13.77M175.64K
Selling, General & Admin6.88M8.10M9.52M11.93M10.88M10.64M10.22M7.62M2.42M134.18K
Research & Development16.53M24.47M29.11M31.83M37.98M38.59M46.30M29.36M11.35M41.45K
Other Operating ExpensesN/A587.00K235.00K37.46MN/AN/AN/AN/A-17.60MN/A
Operating Income-23.41M-32.56M-38.63M-43.76M-48.85M-49.22M-56.52M-36.98M-13.77M-175.64K
Other Expenses / Income-3.62M-8.74M-4.61M37.77M2.18M2.28M861.00K601.00K-17.57MN/A
Before Tax Income-27.03M-41.31M-43.24M-6.00M-46.67M-46.94M-55.66M-36.38M-31.34M-175.64K
Income Tax ExpensesN/A8.74M-5.04M-1.17M-2.92M2.28M-842.00K-594.00K-35.00KN/A
Net Income-27.03M-50.05M-38.20M-4.82M-43.75M-46.94M-55.66M-36.38M-31.34M-175.64K
Interest Expenses1.58M654.00K15.00K540.00K2.18M2.28MN/A601.00KN/AN/A
Basic Shares Outstanding48.03M46.55M41.85M29.48M29.35M27.51M20.49M15.42M20.41M170.00K
Diluted Shares Outstanding48.03M46.55M41.85M29.48M29.35M27.51M20.49M15.42M20.41M170.28K
EBITDA-26.88M-40.94M-42.78M-5.36M-48.85M-46.09M-54.82M-35.78M-31.19M14.64K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-25.45M-40.65M-43.23M-5.46M-44.49M-42.37M-56.51M-36.37M-31.37M-175.64K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙